Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
FuelCell Energy
FCEL
$1.63B
| $5.71M | ﹤0.01% |
119,050
+14,339
| +14% | +$549K |
|
2252
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.48B
| $5.71M | ﹤0.01% |
119,466
-11,114
| -9% | -$521K |
|
2253
Amylyx Pharmaceuticals
AMLX
$2.5B
| $5.71M | ﹤0.01% |
387,620
+21,758
| +6% | +$333K |
|
|
VZIO
2254
DELISTED
VIZIO Holding Corp.
VZIO
| $5.7M | ﹤0.01% |
740,205
+20,826
| +3% | +$130K |
|
2255
Simulations Plus
SLP
$370M
| $5.7M | ﹤0.01% |
127,336
-943
| -0.7% | -$37.4K |
|
2256
CryoPort
CYRX
$766M
| $5.67M | ﹤0.01% |
366,031
+12,008
| +3% | +$157K |
|
|
ALPN
2257
DELISTED
Alpine Immune Sciences Inc
ALPN
| $5.67M | ﹤0.01% |
297,452
+63,196
| +27% | +$878K |
|
2258
Bristow Group
VTOL
$1.38B
| $5.66M | ﹤0.01% |
200,189
+8,548
| +4% | +$231K |
|
2259
VictoryShares Emerging Markets Value Momentum ETF
UEVM
$251M
| $5.66M | ﹤0.01% |
126,937
-1,924
| -1% | -$80.6K |
|
|
BASE
2260
DELISTED
Couchbase
BASE
| $5.64M | ﹤0.01% |
250,472
+19,256
| +8% | +$353K |
|
2261
Blue Bird Corp
BLBD
$2.05B
| $5.6M | ﹤0.01% |
207,594
+32,334
| +18% | +$666K |
|
2262
Citi Trends
CTRN
$621M
| $5.59M | ﹤0.01% |
197,815
+4,779
| +2% | +$116K |
|
2263
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.07B
| $5.58M | ﹤0.01% |
252,920
-45,085
| -15% | -$948K |
|
|
ETNB
2264
DELISTED
89bio
ETNB
| $5.58M | ﹤0.01% |
499,353
+10,349
| +2% | +$95.1K |
|
|
CHUY
2265
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $5.57M | ﹤0.01% |
145,640
-158
| -0.1% | -$5.53K |
|
2266
Aehr Test Systems
AEHR
$4.02B
| $5.56M | ﹤0.01% |
209,670
+9,117
| +5% | +$266K |
|
2267
BHP
BHP
$222B
| $5.54M | ﹤0.01% |
81,119
+27,945
| +53% | +$1.69M |
|
2268
Kinetik
KNTK
$4.16B
| $5.54M | ﹤0.01% |
165,755
+43,346
| +35% | +$1.51M |
|
2269
QuinStreet
QNST
$1.19B
| $5.53M | ﹤0.01% |
431,076
+14,520
| +3% | +$164K |
|
2270
Seadrill
SDRL
$2.94B
| $5.53M | ﹤0.01% |
116,871
-86
| -0.1% | -$3.65K |
|
|
DX
2271
Dynex Capital
DX
$3.23B
| $5.51M | ﹤0.01% |
440,437
+23,000
| +6% | +$263K |
|
2272
Peapack-Gladstone Financial
PGC
$822M
| $5.5M | ﹤0.01% |
184,361
-6,431
| -3% | -$167K |
|
|
CYBR
2273
DELISTED
CyberArk
CYBR
| $5.46M | ﹤0.01% |
24,943
-981
| -4% | -$182K |
|
2274
4D Molecular Therapeutics
FDMT
$609M
| $5.44M | ﹤0.01% |
268,638
+10,130
| +4% | +$133K |
|
|
CHCT
2275
Community Healthcare Trust
CHCT
$433M
| $5.43M | ﹤0.01% |
203,827
+9,511
| +5% | +$262K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.